Evidence map›Paper›PMID 33075691›Full record

ReviewDrug and alcohol dependence2020

Addressing opioid overdose deaths: The vision for the HEALing communities study.

Redonna K Chandler, Jennifer Villani, Thomas Clarke, Elinore F McCance-Katz, Nora D Volkow

Abstract readReview
In one paragraph

Review in Drug and alcohol dependence, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Structural Racism and Coalition Decision-Making: A Qualitative Study of Opioid Prevention and Treatment Implementation.Prevention science : the official journal of the Society for Prevention Research · 2026
    Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Community Advisory Board Members Speak Out: Insights From an Opioid Overdose Study.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Redonna K ChandlerNational Institute on Drug Abuse, National Institutes of Health, 3WFN, 301 North Stonestreet Ave, Bethesda, MD, 20892, United States. Electronic address: redonna.chandler@nih.gov.
Jennifer VillaniNational Institute on Drug Abuse, National Institutes of Health, 3WFN, 301 North Stonestreet Ave, Bethesda, MD, 20892, United States.
Thomas ClarkeSubstance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD, 20852, United States.
Elinore F McCance-KatzSubstance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD, 20852, United States.
Nora D VolkowNational Institute on Drug Abuse, National Institutes of Health, 3WFN, 301 North Stonestreet Ave, Bethesda, MD, 20892, United States.

Funding

Kentucky CAN HEAL (Communities and Networks Helping End Addiction Long-term)UM1DA049406 · NIDA · UNIVERSITY OF KENTUCKY · PI WALSH, SHARON L. · 2019 to 2022
$81.7M
XENOBIOTIC TRANSFER INTO MILK NITROFURANTOINM01RR002602 · NCRR · UNIVERSITY OF KENTUCKY · PI MOSER, DEBRA KAY · 1985 to 2007
$12.1M
NCRR NIH HHS M01 RR002602NIDA NIH HHS UM1 DA049406
6 · The paper itself

Abstract

The United States is facing two devastating public health crises- the opioid epidemic and the COVID-19 pandemic. Within this context, one of the most ambitious implementation studies in addiction research is moving forward. Launched in May 2019, the HEALing Communities Study (HCS) was developed by the National Institutes of Health (NIH) and the Substance Abuse and Mental Health Services Administration (SAMHSA) as part of the Helping to End Addiction Long-termSM Initiative (National Institutes of Health, 2020). The goal for this research was to reduce opioid overdose deaths by 40 % in three years by enhancing and integrating the delivery of multiple evidence-based practices (EBPs) with proven effectiveness in reducing opioid overdose deaths across health care, justice, and community settings. This paper describes the initial vision, goals, and objectives of this initiative; the impact of COVID-19; and the potential for knowledge to be generated from HCS at the intersection of an unrelenting epidemic of opioid misuse and overdoses and the ravishing COVID-19 pandemic.

Indexed as

Analgesics, OpioidCOVID-19Evidence-Based PracticeHumansOpiate OverdoseOpioid-Related DisordersPandemicsPublic HealthUnited StatesUnited States Substance Abuse and Mental Health Services AdministrationAnalgesics, OpioidEvidence-based practicesHEALing communities studyHelping to End Addiction Long-termImplementationMedications for opioid use disorderOpioid use disorderOverdose

Identifiers

PMID33075691
PMCPMC7528974

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.